CTTC

The Vanderbilt Innovation Ambassadors Program is an initiative to provide Vanderbilt and Vanderbilt University Medical Center researchers with better peer-delivered access to assistance and information about innovation and entrepreneurship on campus. Read More

The Vanderbilt Center for Technology Transfer and Commercialization generated more than $100 million in licensing revenue—quadruple its annual average—and reviewed more than 1,000 material transfer agreements and facilitated nearly 300 U.S. patent applications in the 2022 fiscal year. Read More

Padma Raghavan has been reappointed in her role as vice provost, and her title has been updated to vice provost for research and innovation, by Provost and Vice Chancellor for Academic Affairs C. Cybele Raver. Read More

Vanderbilt's Charleson Bell and George Wilson have been named to the 2022 class of a Harvard Business School leadership program focused on communities’ shared growth, prosperity and improved competitiveness on the global stage. Read More

Prothena and the Warren Center for Neuroscience Drug Discovery have entered into a collaborative research agreement to develop new small molecule therapeutics for the treatment of Alzheimer’s disease in individuals with Down syndrome. Read More

Esra Roan, co-founder and CEO of SOMAVAC Medical Solutions, will discuss "Non-linear Career Paths: It is OK to Change Your Mind" on Friday, April 22, at 2 p.m. CT via Zoom.  Read More

Esra Roan will discuss her career journey and why careers need not be linear on April 22.  Read More

Faculty interested in developing novel therapeutics through Ancora Innovation are invited to attend a new three-part Deerfield/Cure lecture series titled “The Discovery of New Therapeutics Drug Development.” Read More

Vanderbilt University has signed an exclusive worldwide license and research collaboration agreement with Neumora Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience. Read More

The Enabling Innovation Initiative will host David Owens, professor of the practice of management and innovation and Evans Family Executive Director of the Wond'ry, Vanderbilt’s Innovation Center, for “Inside the Box: Innovative Within Constraints” on Friday, Feb. 18, at 2 p.m. CT. Read More

Nine startups established at Vanderbilt’s Center for Technology Transfer and Commercialization and the Wond’ry have been awarded more than $4.5 million in federal Small Business Innovation Research and Small Business Technology Transfer grants and matching funds from Launch Tennessee, with the goal of accelerating technology commercialization, innovation and job creation across the state. Read More

Using robotics to help individuals walk seemed like something out of a science fiction film until Michael Goldfarb and members of his lab made it a reality. Read More

L.J. Zwiebel and his lab show that mosquito larvae, the age group targeted for most control programs, are far more sophisticated than previously thought. Est. reading time: 2 mins. Read More

Vanderbilt University ranks 35th on the list of the top 100 worldwide universities granted U.S. utility patents in 2020. This is up one spot from 2019. Read More

The Center for Technology Transfer and Commercialization continued to play a pivotal role in translating the research findings of Vanderbilt faculty into products and companies in 2020 that have the potential to transform many aspects of life, from disease prevention to quality of life-enhancing products. Read More

A new Nanomaker Immersion course coming to Vanderbilt aims to train the next generation of nanotechnology entrepreneurs in a facility rarely utilized by undergraduates. Vanderbilt professor Alice D. Leach will teach nanotech development and commercialization techniques to the next generation of nanotechnology entrepreneurs beginning in fall 2022. Read More

An interdisciplinary fellowship with the Data Science Institute has resulted in a promising machine-learning technology that can effectively track complex surgical activity, having the potential to improve patient outcomes, safety and documentation. Read More

A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Read More

Further research by biochemistry professors Charles Sanders and  Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research. Read More

Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read More